Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 19, 2023
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
Mon, September 18, 2023
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
[ Mon, Sep 18th 2023
] - WOPRAI
Raghuram Selvaraju Initiated (ANEB) at Strong Buy and Held Target at $6 on, Sep 18th, 2023
Raghuram Selvaraju of HC Wainwright & Co., Initiated "Anebulo Pharmaceuticals, Inc." (ANEB) at Strong Buy and Held Target at $6 on, Sep 18th, 2023.
Raghuram has made no other calls on ANEB in the last 4 months.
There is 1 other peer that has a rating on ANEB. Out of the 1 peers that are also analyzing ANEB, 0 agree with Raghuram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Raghuram
- Robert Wasserman of "Benchmark" Reiterated at Buy and Held Target at $8 on, Thursday, May 18th, 2023
